BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 24851890)

  • 1. [Plasma DNA methylation of shp1 in patients with diffuse large B cell lymphoma].
    Chen X; Fu R; Wang Y; Song W; Ruan E; Qu W; Wang H; Wang G; Song J; Wang X; Wu Y; Xing L; Liu H; Li L; Guan J; Shao Z
    Zhonghua Yi Xue Za Zhi; 2014 Apr; 94(14):1071-5. PubMed ID: 24851890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma DNA methylation of p16 and shp1 in patients with B cell non-Hodgkin lymphoma.
    Ding K; Chen X; Wang Y; Liu H; Song W; Li L; Wang G; Song J; Shao Z; Fu R
    Int J Clin Oncol; 2017 Jun; 22(3):585-592. PubMed ID: 28210822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MGMT methylation in diffuse large B-cell lymphoma: validation of quantitative methylation-specific PCR and comparison with MGMT protein expression.
    Uccella S; Cerutti R; Placidi C; Marchet S; Carnevali I; Bernasconi B; Proserpio I; Pinotti G; Tibiletti MG; Furlan D; Capella C
    J Clin Pathol; 2009 Aug; 62(8):715-23. PubMed ID: 19638543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoter methylation attenuates SHP1 expression and function in patients with primary central nervous system lymphoma.
    Liu J; Wang Y; Sun X; Ji N; Sun S; Wang Y; Liu F; Cui Q; Wang C; Liu Y
    Oncol Rep; 2017 Feb; 37(2):887-894. PubMed ID: 27959415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SHP1 loss augments DLBCL cellular response to ibrutinib: a candidate predictive biomarker.
    Wu W; Lu P; Patel P; Ma J; Cai KQ; Mallikarjuna VS; Poureghbali S; Nakhoda SR; Nejati R; Lynn Wang Y
    Oncogene; 2023 Feb; 42(6):409-420. PubMed ID: 36482202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between promoter hypermethylation of GSTP1 and response to chemotherapy in diffuse large B cell lymphoma.
    Nakamichi I; Tomita Y; Zhang B; Sugiyama H; Kanakura Y; Fukuhara S; Hino M; Kanamaru A; Ogawa H; Aozasa K
    Ann Hematol; 2007 Aug; 86(8):557-64. PubMed ID: 17508213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PCR-based clonality analysis in diffuse large B-cell lymphoma using BIOMED-2 primers of IgH (FR3) on formalin-fixed paraffin-embedded tissue.
    Kosari F; Shishehbor F; Saffar H; Sadeghipour A
    Arch Iran Med; 2013 Sep; 16(9):526-9. PubMed ID: 23981156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypermethylation of CpG islands in p16 as a prognostic factor for diffuse large B-cell lymphoma in a high-risk group.
    Shiozawa E; Takimoto M; Makino R; Adachi D; Saito B; Yamochi-Onizuka T; Yamochi T; Shimozuma J; Maeda T; Kohno Y; Kawakami K; Nakamaki T; Tomoyasu S; Shiokawa A; Ota H
    Leuk Res; 2006 Jul; 30(7):859-67. PubMed ID: 16406514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible Role of GADD45γ Methylation in Diffuse Large B-Cell Lymphoma: Does It Affect the Progression and Tissue Involvement?
    Barış İC; Caner V; Şen Türk N; Sarı İ; Hacıoğlu S; Doğu MH; Çetin O; Tepeli E; Can Ö; Bağcı G; Keskin A
    Turk J Haematol; 2015 Dec; 32(4):295-303. PubMed ID: 25912017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic changes and their clinical relevance in Saudi diffuse large B-cell lymphoma. A molecular and tissue microarray analysis of 100 cases.
    Al-Kuraya KS; Siraj AK; Al-Dayel FA; Ezzat AA; Al-Jommah NA; Atizado VL; Narayanappa RN
    Saudi Med J; 2005 Jul; 26(7):1099-103. PubMed ID: 16047061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant DNA methylation of the p57KIP2 gene is a sensitive biomarker for detecting minimal residual disease in diffuse large B cell lymphoma.
    Hagiwara K; Li Y; Kinoshita T; Kunishma S; Ohashi H; Hotta T; Nagai H
    Leuk Res; 2010 Jan; 34(1):50-4. PubMed ID: 19616848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased expression level of SH2 domain-containing protein tyrosine phosphatase-1 (Shp1) is associated with progression of chronic myeloid leukaemia.
    Amin HM; Hoshino K; Yang H; Lin Q; Lai R; Garcia-Manero G
    J Pathol; 2007 Aug; 212(4):402-10. PubMed ID: 17503411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic polymorphisms of methylenetetrahydrofolate reductase and promoter methylation of MGMT and FHIT genes in diffuse large B cell lymphoma risk in Middle East.
    Siraj AK; Ibrahim M; Al-Rasheed M; Bu R; Bavi P; Jehan Z; Abubaker J; Murad W; Al-Dayel F; Ezzat A; El-Solh H; Uddin S; Al-Kuraya K
    Ann Hematol; 2007 Dec; 86(12):887-95. PubMed ID: 17712558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of the chromosomal translocation t(11;18) in some mucosa-associated lymphoid tissue lymphomas and diffuse large B-cell lymphomas of the ocular adnexa: evidence from multiplex reverse transcriptase-polymerase chain reaction and fluorescence in situ hybridization on using formalin-fixed, paraffin-embedded specimens.
    Takada S; Yoshino T; Taniwaki M; Nakamura N; Nakamine H; Oshima K; Sadahira Y; Inagaki H; Oshima K; Tadaatsu A
    Mod Pathol; 2003 May; 16(5):445-52. PubMed ID: 12748251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylation of SHP1 gene and loss of SHP1 protein expression are frequent in systemic anaplastic large cell lymphoma.
    Khoury JD; Rassidakis GZ; Medeiros LJ; Amin HM; Lai R
    Blood; 2004 Sep; 104(5):1580-1. PubMed ID: 15317731
    [No Abstract]   [Full Text] [Related]  

  • 16. Quantitative evaluation of p16(INK4a) promoter methylation using pyrosequencing in de novo diffuse large B-cell lymphoma.
    Zainuddin N; Kanduri M; Berglund M; Lindell M; Amini RM; Roos G; Sundström C; Enblad G; Rosenquist R
    Leuk Res; 2011 Apr; 35(4):438-43. PubMed ID: 21035853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of hematopoietic cell-specific tyrosine phosphatase SHP-1 gene expression in natural killer cell lymphoma and various types of lymphomas/leukemias : combination analysis with cDNA expression array and tissue microarray.
    Oka T; Yoshino T; Hayashi K; Ohara N; Nakanishi T; Yamaai Y; Hiraki A; Sogawa CA; Kondo E; Teramoto N; Takahashi K; Tsuchiyama J; Akagi T
    Am J Pathol; 2001 Oct; 159(4):1495-505. PubMed ID: 11583976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential methylation of genes that regulate cytokine signaling in lymphoid and hematopoietic tumors.
    Reddy J; Shivapurkar N; Takahashi T; Parikh G; Stastny V; Echebiri C; Crumrine K; Zöchbauer-Müller S; Drach J; Zheng Y; Feng Z; Kroft SH; McKenna RW; Gazdar AF
    Oncogene; 2005 Jan; 24(4):732-6. PubMed ID: 15580314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Several mechanisms lead to the inactivation of the CDKN2A (P16), P14ARF, or CDKN2B (P15) genes in the GCB and ABC molecular DLBCL subtypes.
    Guney S; Jardin F; Bertrand P; Mareschal S; Parmentier F; Picquenot JM; Tilly H; Bastard C
    Genes Chromosomes Cancer; 2012 Sep; 51(9):858-67. PubMed ID: 22619049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Splenic large B-cell lymphoma in patients with hepatitis C virus infection.
    Takeshita M; Sakai H; Okamura S; Oshiro Y; Higaki K; Nakashima O; Uike N; Yamamoto I; Kinjo M; Matsubara F
    Hum Pathol; 2005 Aug; 36(8):878-85. PubMed ID: 16112004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.